Press release
Urea Cycle Disorders Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Callitas, Poseida Therapeutics, Promethera, Arcturus, Kaleido, Akaza Biopharma, Evox Therapeutics, Dipharma, Aeglea, ERYTECH
"Urea Cycle Disorders Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Urea Cycle Disorders Therapeutics Market.
The report provides a detailed description of the Urea Cycle Disorders drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Urea Cycle Disorders Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/urea-cycle-disorders-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Urea Cycle Disorders Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Urea Cycle Disorders therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Urea Cycle Disorders treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Urea Cycle Disorders drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Urea Cycle Disorders treatment market.
Learn More about the Clinical and Commercial Development Activities in the Urea Cycle Disorders Therapeutics Domain:
https://www.delveinsight.com/report-store/urea-cycle-disorders-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Urea Cycle Disorders Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Urea Cycle Disorders pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Urea Cycle Disorders Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/urea-cycle-disorders-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Urea Cycle Disorders Therapeutics Analysis
There are approx. 8+ key companies are developing therapies for Urea Cycle Disorders. Currently, Acer Therapeutics is leading the therapeutics market with its Urea Cycle Disorders drug candidates in the most advanced stage of clinical development.
Urea Cycle Disorders Companies in the Therapeutics Market Include:
• Acer Therapeutics
• Dimension Therapeutics
• Callitas Therapeutics
• Poseida Therapeutics
• Promethera Biosciences
• Arcturus Therapeutics
• Kaleido Biosciences
• Akaza Biopharma
• Evox Therapeutics
• Dipharma SA
• Sana Biotechnology
• Aeglea BioTherapeutics
• ERYTECH
And Many Others
Emerging and Marketed Urea Cycle Disorders Therapies Covered in the Report Include:
• ACER-001: Acer Therapeutics
• Avalotcagene ontaparvovec: Dimension Therapeutics
And Many More
Get an in-depth Assessment of the Emerging Therapies and Urea Cycle Disorders Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/urea-cycle-disorders-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Urea Cycle Disorders Current Treatment Patterns
4. Urea Cycle Disorders - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Urea Cycle Disorders Late-Stage Products (Phase-III)
7. Urea Cycle Disorders Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Urea Cycle Disorders Discontinued Products
13. Urea Cycle Disorders Product Profiles
14. Urea Cycle Disorders Companies
15. Urea Cycle Disorders Drugs
16. Dormant and Discontinued Products
17. Urea Cycle Disorders Unmet Needs
18. Urea Cycle Disorders Future Perspectives
19. Urea Cycle Disorders Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/urea-cycle-disorders-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Indolent Lymphoma Market
https://www.delveinsight.com/report-store/indolent-lymphoma-market
Lipodystrophy Market
https://www.delveinsight.com/report-store/lipodystrophy-market
Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
Anaplastic Astrocytoma Market
https://www.delveinsight.com/report-store/anaplastic-astrocytoma-market
Singapore Healthcare Outlook
https://www.delveinsight.com/report-store/singapore-healthcare-outlook-report
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market
https://www.delveinsight.com/report-store/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-market
Chronic Idiopathic Constipation Market
https://www.delveinsight.com/report-store/chronic-idiopathic-constipation-market
Hay Fever Conjunctivitis Market
https://www.delveinsight.com/report-store/hay-fever-conjunctivitis-market
Nasopharyngeal Carcinoma Market
https://www.delveinsight.com/report-store/nasopharyngeal-carcinoma-market
Cerebral Infarction Market
https://www.delveinsight.com/report-store/cerebral-infarction-market
CART-related Neurotoxicity (NT) Market
https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market
Hernia Repair Devices Market
https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bronchial Hyperreactivity Market
https://www.delveinsight.com/report-store/bronchial-hyperreactivity-market
Chronic Focal Epilepsy Market
https://www.delveinsight.com/report-store/chronic-focal-epilepsy-market
Dental Lasers Market
https://www.delveinsight.com/report-store/dental-lasers-market
Down Syndrome Market
https://www.delveinsight.com/report-store/down-syndrome-market
Extracorporeal Circulation System Market
https://www.delveinsight.com/report-store/extracorporeal-circulation-system-market
Failed Back Surgery Syndrome Market
https://www.delveinsight.com/report-store/failed-back-surgery-syndrome-market
Germ Cell Tumor Market
https://www.delveinsight.com/report-store/germ-cell-tumor-market
Hot Flashes Market
https://www.delveinsight.com/report-store/hot-flashes-market
India Healthcare Outlook
https://www.delveinsight.com/report-store/india-healthcare-outlook-report
Insulin Glargine Biosimilar
https://www.delveinsight.com/report-store/insulin-glargine-biosimilar-insight
Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market
Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market
Nasolabial Fold Market
https://www.delveinsight.com/report-store/nasolabial-fold-market
Neuroleptic Malignant Syndrome Market
https://www.delveinsight.com/report-store/neuroleptic-malignant-syndrome-market
Pachyonychia Congenita Market
https://www.delveinsight.com/report-store/pachyonychia-congenita-market
Point of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
Reactive Airway Disease Market
https://www.delveinsight.com/report-store/reactive-airway-disease-market
Seborrhea Market
https://www.delveinsight.com/report-store/seborrhea-market
Substance (Drug) Abuse Market
https://www.delveinsight.com/report-store/substance-drug-abuse-market
Synchronous Endometrial and Ovarian Cancer (SEOC) Market
https://www.delveinsight.com/report-store/synchronous-endometrial-and-ovarian-cancer-seoc-market
Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight
Urinary Tract Infection Devices Market
https://www.delveinsight.com/report-store/urinary-tract-infection-devices-market
Varicose Veins Market
https://www.delveinsight.com/report-store/varicose-veins-market
Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urea Cycle Disorders Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Callitas, Poseida Therapeutics, Promethera, Arcturus, Kaleido, Akaza Biopharma, Evox Therapeutics, Dipharma, Aeglea, ERYTECH here
News-ID: 3166531 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Urea
Urea Market Size, Share, Analysis & Forecast 2034
Global Urea Market Outlook
The global urea market reached a volume of 177.21 million metric tons (MMT) in 2024 and is expected to grow at a CAGR of 0.90% between 2025 and 2034. By 2034, the market is projected to reach a volume of 193.82 MMT, driven primarily by the growing demand for urea as a fertilizer in the agricultural sector. Urea is a vital nitrogen-based fertilizer, widely used to improve…
Global Marine Urea Solution Market Size by Application, Type, and Geography: For …
According to Market Research Intellect, the global Marine Urea Solution market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for marine urea solutions is expanding significantly due to stricter environmental rules that aim to lower…
Urea market: Market Indicators Showing Positive Outlook
The new report published by The Business Research Company, titled Urea Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the urea market size has grown steadily in recent years. It will grow from $47.64 billion in 2023…
Granular Urea Market: Cultivating Growth and Fertility with Premium Granular Ure …
The Worldwide "Granular Urea Market" 2023 Research Report presents a professional and complete analysis of the Global Granular Urea Market in the current situation. This report includes development plans and policies along with Granular Urea manufacturing processes and price structures. the reports 2023 research report offers an analytical view of the industry by studying different factors like Granular Urea Market growth, consumption volume, Size, revenue, share, trends, and Granular Urea…
Urea Market: Asia-Pacific to Lead Urea Market Growth with Rapid Industrializatio …
[100+ Pages Report] | Global "Urea Market" research report provides Innovative Insights on the Strategies adopted by Major Global in the worldwide industry. This valuable information offers businesses and investors a clear understanding of the market's Competitive Landscape, Growth Potential, and Impending Opportunities. The modern report highlights Latest Mergers, Achievements, Revenue Offshoring, R & D, Development Plans, Progression Growth, and Collaborations.
The global urea market size was valued at USD 107.28…
Polymer Sulphur Coated Urea Accounts for Over 90% of the Sales of Global Sulphur …
The impact of the COVID-19 outbreak has compelled several manufacturers and industries to rethink their operations to gradually recover from the losses incurred for years to come. The organic chemicals industry suffered a huge setback due to halted production and a limited supply of raw materials.
The report offers actionable and valuable market insights of Polymer Sulphur Coated Urea. The latest report by Fact.MR provides details on the present scenario of the…
